Abstract
Purpose
The aim of this study was to elucidate the clinical features and symptoms of IgG4-related ophthalmic disease (IgG4-ROD).
Study design
Retrospective, multicenter study.
Methods
The medical charts of 378 patients with IgG4-ROD diagnosed at 9 hospitals in Japan were reviewed. The demographic profiles, clinical findings, and ocular symptoms of the patients were analyzed.
Results
On the basis of the diagnostic criteria for IgG4-ROD, the diagnosis was definite in 261 patients (69%), probable in 45 patients (12%), and possible in 72 patients (19%). The patients’ mean age at the time of diagnosis was 60.6 ± 13.9 years; 195 (52%) were male. The mean IgG4 serum level at the time of the initial diagnosis was 578.9 mg/dL. Imaging studies showed pathologic lesions as follows: lesions in the lacrimal glands (86%), extraocular muscles (21%), trigeminal nerve (20%), and eyelids (12%); isolated orbital mass (11%); diffuse orbital lesion (8%); lesion in the perioptic nerve (8%); and lesion in the sclera (1%). The ophthalmic symptoms included dry eye (22%), diplopia (20%), decreased vision (8%), and visual field defects (5%). IgG4-ROD with extraocular lesions was observed in 182 patients (48%).
Conclusion
Although the lacrimal glands are well known to be the major pathologic site of IgG4-ROD, various ocular tissues can be affected and cause ophthalmic symptoms including visual loss.
Similar content being viewed by others
References
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire J-F, et al. The 2019 American college of rheumatology/european league against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79:77–87.
Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, et al. The 2020 revised diagnostic criteria for IgG4-related disease. Mod Rheumatol. 2020;4:1–14.
Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335–40.
Sogabe Y, Ohshima K, Azumi A, Takahira M, Kase S, Tsuji H, et al. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol. 2014;252:531–8.
Goto H, Takahira M, Azumi A. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1–7.
Uchida K, Masamune A, Shimosegawa T, Okazaki K. Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol. 2012;2012: 358371. https://doi.org/10.1155/2012/358371.
Japanese Study Group of IgG4-Related Ophthalmic Disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;57:573–9.
Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.
Kashii S. IgG4-related disease: a neuro-ophthalmological perspective. J Neuroophthalmol. 2014;34:400–7.
Li J, Zhang Y, Zhou H, Wang L, Wang Z, Li H. Magnetic resonance imaging indicator of the causes of optic neuropathy in IgG4-related ophthalmic disease. BMC Med Imaging. 2019;19:49.
Hong JW, Kang S, Song MK, Ahn CJ, Sa HS. Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease. Br J Ophthalmol. 2018;102:1591–5.
Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E, et al. Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series. Medicine. 2017;96: e6205. https://doi.org/10.1097/md.0000000000006205.
Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019;78:406–12.
Kawa S, Skold M, Ramsden DB, Parker A, Harding SJ. Serum IgG4 concentration in IgG4-related disease. Clin Lab. 2017;63:1323–37.
Woo YJ, Kim JW, Yoon JS. Clinical implications of serum IgG4 levels in patients with IgG4-related ophthalmic disease. Br J Ophthalmol. 2017;101:256–60.
Brito-Zerón P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine. 2016;95:e4002-e. https://doi.org/10.1097/MD.0000000000004002.
Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56:1719–24.
Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, et al. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. Sci Rep. 2018;8:10262. https://doi.org/10.1038/s41598-018-28405-x.
Andrew NH, Gajdatsy A, Selva D. Intraorbital corticosteroid injection for the treatment of IgG4-related ophthalmic disease. Br J Ophthalmol. 2016;100:644–7.
Ominato J, Oyama T, Cho H, Shiozaki N, Umezu H, Takizawa J, et al. The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study. BMJ Open Ophthalmol. 2019;4: e000295. https://doi.org/10.1136/bmjophth-2019-000295.
Acknowledgements
This work was supported by the Japanese Ministry of Health, Labor and Welfare Research Program on Rare and Intractable Diseases, grant number JPMH20FC1040.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
H. Goto, None; S. Ueda, None; R. Nemoto, None; K. Ohshima, None; Y. Sogabe, None; K. Kitagawa, None; Y. Ogawa, None; T. Oyama, None; M. Furuta, None; A. Azumi, None; M. Takahira, None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding Author: Hiroshi Goto
About this article
Cite this article
Goto, H., Ueda, Si., Nemoto, R. et al. Clinical features and symptoms of IgG4-related ophthalmic disease: a multicenter study. Jpn J Ophthalmol 65, 651–656 (2021). https://doi.org/10.1007/s10384-021-00847-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-021-00847-3